Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Colon Cancer
100%
Metastasis
100%
Cancer Stem Cells
100%
Cancer Relapse
100%
Circulating Cancer Stem Cells
100%
Circulating Tumor Cells
42%
Relapse Risk
28%
Colon Adenocarcinoma
28%
Metastatic Disease
28%
Metastatic Tumor
28%
Cancer Stem Cell Markers
28%
Red Blood Cells
14%
High Risk
14%
Clinical Outcomes
14%
Colon Cancer Patients
14%
Conventional Treatment
14%
Annexin A2 (ANXA2)
14%
Cluster of Differentiation 44 (CD44)
14%
Cancer Disease
14%
Metastatic Cancer
14%
White Blood Cells
14%
Cancer Inpatients
14%
Malignant Phenotype
14%
Non-invasive Diagnostics
14%
Epithelial-mesenchymal Transition
14%
Doublecortin-like Kinase 1 (DCLK1)
14%
Cytokeratin 19 (CK19)
14%
CD45
14%
Athymic nude Mice
14%
Epithelial Markers
14%
Non-cancer
14%
Detection Accuracy
14%
Invasive Diagnostic Procedures
14%
Relapsed Disease
14%
Tumor-initiating Cells
14%
Metastatic Growth
14%
CD45+
14%
Inhibitory Agents
14%
Metastatic Relapse
14%
TGR5
14%
Novel Diagnostics
14%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Colon Carcinoma
100%
Cancer Recurrence
100%
Neoplasm
22%
Cell Marker
16%
Lipocortin 2
5%
Adenocarcinoma
5%
Nude Mouse
5%
Colon Adenocarcinoma
5%
Diseases
5%
Immunology and Microbiology
Colon
100%
Cancer Stem Cell
100%
Cell Marker
18%
Circulating Tumor Cell
18%
Leukocyte
6%
Nude Mouse
6%
CD44
6%
Tumor Spheroid
6%
Epithelial Mesenchymal Transition
6%
Erythrocyte
6%